PB Ratio of Molbio Diagnostics Ltd
Molbio Diagnostics Ltd
NSE: MOLBIO
PB Ratio
Key Highlights
- The latest PB Ratio of Molbio Diagnostics Ltd is 10.5.
- The PB ratio of the Molbio Diagnostics Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors The P/B Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years .
Historical P/B Ratio of Molbio Diagnostics Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Molbio Diagnostics Ltd
Company Fundamentals for null
Market Cap
14,360 Cr
EPS
14.5
P/E Ratio (TTM)
85.9
P/B Ratio (TTM)
10.5
Day’s High
1256.9
Day’s Low
1217.6
DTE
0.4
ROE
14.2
52 Week High
1686.5
52 Week Low
925.8
ROCE
16.2
Market Price of Molbio Diagnostics Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 25 Sep 2026 | 1246.15 |
| 24 Sep 2026 | 1246.2 |
| 23 Sep 2026 | 1310.4 |
| 22 Sep 2026 | 1265.05 |
| 21 Sep 2026 | 1219.35 |
| 18 Sep 2026 | 1288.6 |
| 17 Sep 2026 | 1285.05 |
| 16 Sep 2026 | 1312.65 |
| 15 Sep 2026 | 1361.4 |
| 11 Sep 2026 | 1441.6 |
SWOT Analysis Of Molbio Diagnostics Ltd
BlinkX Score for Molbio Diagnostics Ltd
Asset Value vs Market Value of Molbio Diagnostics Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
| Company | PB | Market Cap |
|---|
| Molbio Diagnostics Ltd | 10.49 | 14360 |
| Apollo Hospitals Enterprise Ltd | 692.9 | 127823 |
| Max Healthcare Institute Ltd | 91.8 | 98694 |
| Manipal Health Enterprises Ltd | 65.9 | 95621 |
| Aster DM Quality Care Ltd | 49.2 | 66182 |
PB Ratio of Molbio Diagnostics Ltd Explained
₹14360
Market cap
₹119
Book Value per Share
10.5X
PB Ratio
Historical Market Cap of Molbio Diagnostics Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Molbio Diagnostics Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Molbio Diagnostics Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Molbio Diagnostics Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Molbio Diagnostics Ltd News Hub
Molbio Diagnostics IPO subscribed 83%
The initial public offer of Molbio Diagnostics received bids for 67,67,496 shares as against 81,58,5
Read more
10 Aug 26
Stock Alert: Tata Motors, Mazagon Dock, Brigade Ent, RVNL, Cohance Life
Securities in F&O Ban: Shares of Inox Wind, Kaynes Technology, LIC Housing Finance and SAIL barred f
Read more
07 Sept 26
Molbio Diagnostics reports consolidated net profit of Rs 58.75 crore in the June 2026 quarter
Net profit of Molbio Diagnostics reported to Rs 58.75 crore in the quarter ended June 2026 as agains
Read more
07 Sept 26
Molbio Diagnostics IPO subscribed 70.26 times
The initial public offer of Molbio Diagnostics received bids for 57,32,14,536 shares as against 81,5
Read more
12 Aug 26
